Composite Primary Symptom Reduction Score (CPSR) Scale from: ‐100 to 100 Higher score = better · people with irritable bowel syndrome
1 finding from 1 review
Composite Primary Symptom Reduction Score (CPSR) Scale from: ‐100 to 100 Higher score = better · people with irritable bowel syndrome
1 finding from 1 review
Composite Primary Symptom Reduction Score (CPSR) Scale from: ‐100 to 100 Higher score = better · people with irritable bowel syndrome
1 finding from 1 review
Remission · Patients with active Crohn's disease
It is very uncertain whether intervention diet changes induction of remission at 4 weeks ‐ High‐fiber, low refined… compared with control diet (very low certainty).
2 findings from 1 review
QoL · Patients with active Crohn's disease
1 finding from 1 review
Intervention not reported
Quality of life (QoL) Inflammatory Bowel Disease Questionnaire (IBDQ) (scale: 32 to 224; higher score = better QoL) · Patients with active Crohn's disease
1 finding from 1 review
Intervention not reported
Self‐perceived QoL (change from baseline) measured using Peds QL 4.0 Generic Core Scales, scoring 0‐100 points, higher score indicates better quality of life) · children with chronic constipation
1 finding from 1 review
Intervention not reported
Parent‐perceived QoL (change from baseline) measured using PedsQL 4.0 Generic Core Scales, scoring 0‐100 points, higher score indicates better quality of life) · children with chronic constipation
1 finding from 1 review
Intervention not reported
Open surgical drainage versus EUS‐guided drainage Scale from: 0 to 100. Higher indicates better · patients with pancreatic pseudocysts
1 finding from 1 review
Maintenance of clinical remission · Participants with Crohn's disease in remission
Methotrexate probably leads to higher proportion of patients maintaining clinical remission (high dose… compared with placebo (moderate certainty).
1 finding from 1 review
Recurrent and persistent bleeding overall rates with or without second‐look endoscopy Rebleeding (persistent or recurrent bleeding) · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower recurrent and persistent bleeding overall rates with or without… compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Surgery rate Number requiring emergency surgery · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower surgery rate Number requiring emergency surgery compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Mortality rate Number of deaths (30‐day mortality or in‐hospital mortality) · patients with high‐risk bleeding ulcers
Epinephrine probably leads to lower mortality rate Number of deaths (30‐day mortality or in‐hospital… compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review
Adverse effects of endoscopy therapy Adverse effects · patients with high‐risk bleeding ulcers
Epinephrine probably leads to higher adverse effects of endoscopy therapy Adverse effects compared with epinephrine and any second endoscopic method (moderate certainty).
1 finding from 1 review